An historical approach to the diagnostic biomarkers of acute coronary syndrome

Annals of Translational Medicine

Volumn 4, Issue 10, 2016, Pages

  Danese, Elisa ^a   Montagnana, Martina ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Acute coronary syndromes (ACS); Acute myocardial infarction (AMI); Cardiac biomarkers; Cardiac troponin

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CREATINE KINASE; CREATINE KINASE MB; LACTATE DEHYDROGENASE; TROPONIN; TROPONIN C; TROPONIN I; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOMATION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ELECTROPHORESIS; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GOLD STANDARD; HEART MUSCLE NECROSIS; HISTORY OF MEDICINE; HUMAN; IMMUNOASSAY; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; LIMIT OF DETECTION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PREDICTIVE VALUE; RADIOIMMUNOASSAY; RELIABILITY; SENSITIVITY AND SPECIFICITY; X RAY DIFFRACTION;

EID: 85006219401     PISSN: 23055839     EISSN: 23055847     Source Type: Journal    
DOI: 10.21037/atm.2016.05.19     Document Type: Article

References (125)

1. Bhatnagar P, Wickramasinghe K, Williams J, et al. The epidemiology of cardiovascular disease in the UK 2014. Heart 2015;101:1182-9.
2. Wilmot KA, O'Flaherty M, Capewell S, et al. Coronary heart disease mortality declines in the united states from 1979 through 2011: evidence for stagnation in young adults, especially women. Circulation 2015;132:997-1002.
3. Makam AN, Nguyen OK. Use of cardiac biomarker testing in the emergency department. JAMA Intern Med 2015;175:67-75.
4. Storrow AB, Gibler WB. Chest pain centers: diagnosis of acute coronary syndromes. Ann Emerg Med 2000;35:449-61.
5. Kumar A, Cannon CP. Acute coronary syndromes: diagnosis and management, part I. Mayo Clin Proc 2009;84:917-38.
6. Wenaweser P, Windecker S. Acute coronary syndromes: management and secondary prevention. Herz 2008;33:25-37.
7. Goodacre S, Thokala P, Carroll C, et al. Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome. Health Technol Assess 2013;17:v-vi, 1-188.
8. Rosalki SB, Roberts R, Katus HA, et al. Cardiac biomarkers for detection of myocardial infarction: perspectives from fast to present. Clin Chem 2004;50:2205-13.
9. Lippi G, Montagnana M, Salvagno GL, et al. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 2006;8:27-31.
10. Gamble JH, Carlton EW, Orr WP, et al. High-sensitivity cardiac troponins: no more 'negatives'. Expert Rev Cardiovasc Ther 2013;11:1129-39.
11. Wu AH. Cardiac markers: from enzymes to proteins, diagnosis to prognosis, laboratory to bedside. Ann Clin Lab Sci 1999;29:18-23.
12. Lippi G. Biomarkers: Novel troponin immunoassay for early ACS rule-out. Nat Rev Cardiol 2016;13:9-10.
13. Dolci A, Panteghini M. The exciting story of cardiac biomarkers: from retrospective detection to gold diagnostic standard for acute myocardial infarction and more. Clin Chim Acta 2006;369:179-87.
14. Ladue JS, Wroblewski F, Karmen A. Serum glutamic oxaloacetic transaminase activity in human acute transmural myocardial infarction. Science 1954;120:497-9.
15. Karmen A, Wroblewski F, LaDue JS. Transaminase activity in human blood. J Clin Invest 1955;34:126-31.
16. Karmen A. A note on the spectrophotometric assay of glutamic-oxaloacetic transaminase in human blood serum. J Clin Invest 1955;34:131-3.
17. Henry RJ, Chiamori N, Golub OJ, et al. Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase. Am J Clin Pathol 1960;34:381-98.
18. Wilkinson JH, Baron DN, Moss DW, et al. Standardization of clinical enzyme assays: a reference method for aspartate and alanine transaminases. J Clin Pathol 1972;25:940-4.
19. Penttilä I, Penttilä K, Rantanen T. Laboratory diagnosis of patients with acute chest pain. Clin Chem Lab Med 2000;38:187-97.
20. Johnston CC, Bolton EC. Cardiac enzymes. Ann Emerg Med 1982;11:27-35.
21. Boyde TR, Kwong EM. Aspartate aminotransferase isoenzymes--differential kinetic assay in serum. Clin Chim Acta 1983;128:95-102.
22. Boyde TR. Serum levels of the mitochondrial isoenzyme of aspartate aminotransferase in myocardial infarction and muscular dystrophy. Enzymol Biol Clin (Basel) 1968;9:385-92.
23. Rabkin SW, Desjardins P. Mitochondrial and cytoplasmatic isoenzymes of aspartate aminotransferase in sera of patients after myocardial infarction. Clin Chim Acta 1984;138:245-57.
24. Panteghini M, Pagani F, Cuccia C. Activity of serum aspartate aminotransferase isoenzymes in patients with acute myocardial infarction. Clin Chem 1987;33:67-71.
25. Hill BR, Levi C. Elevation of a serum component in neoplastic disease. Cancer Res 1954;14:513-5.
26. Wroblewski F, LaDue JS. Lactic dehydrogenase activity in blood. Proc Soc Exp Biol Med 1955;90:210-3.
27. Wróblewski F, Ruegsegger P, LaDue JS. Serum lactic dehydrogenase activity in acute transmural myocardial infarction. Science 1956;123:1122-3.
28. Ulmer DD, Vallee BL, Wacker WE. Metalloenzymes and myocardial infarction. II. Malic and lactic dehydrogenase activities and zinc concentrations in serum. N Engl J Med 1956;255:450-6.
29. Wróblewski F, Ross C, Gregory K. Isoenzymes and myocardial infarction. N Engl J Med 1960;263:531-6.
30. Konttinen A. Hydroxybutyrate dehydrogenase in detection of myocardial infarction. Lancet 1961;2:556-8.
31. Galbraith LV, Leung FY, Jablonsky G, et al. Time related changes in the diagnostic utility of total lactate dehydrogenase, lactate dehydrogenase isoenzyme-1, and two lactate dehydrogenase isoenzyme-1 ratios in serum after myocardial infarction. Clin Chem 1990;36:1317-22.
32. Oliver IT. A spectrophotometric method for the determination of creatine phosphokinase and myoldnase. Biochem J 1955;61:116-22.
33. Tanzer ML, Gilvarg C. Creatine and creatine measurement. J Biol Chem 1959;234:3201-4.
34. Rosalki SB. An improved procedure for serum creatine phosphokinase determination. J Lab Clin Med 1967;69:696-705.
35. Kornberg A. Reversible enzymatic synthesis of diphosphopyridine nucleotide and inorganic pyrophosphate. J Biol Chem 1948;176:1475.
36. Schumann G, Bonora R, Ceriotti F, et al. IFCC primary reference procedures for the measurement of catalytic activity concentrations of enzymes at 37 °C. Part 2. Reference procedure for the measurement of catalytic concentration of creatine kinase. Clin Chem Lab Med 2002;40:635-42.
37. Dreyfus JC, Schapira G, Rasnais J, et al. Serum creatine kinase in the diagnosis of myocardial infarct. Rev Fr Etud Clin Biol 1960;5:386-7.
38. Sorensen NS. Creatine phosphokinase in the diagnosis of myocardial infarction. Acta Med Scand 1963;174:725-34.
39. Shell WE, Kjekshus JK, Sobel BE. Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity. J Clin Invest 1971;50:2614-25.
40. Sobel BE, Bresnahan GF, Shell WE, et al. Estimation of infarct size in man and its relation to prognosis. Circulation 1972;46:640-8.
41. Panteghini M. Enzyme and muscle diseases. Curr Opin Rheumatol 1995;7:469-74.
42. Puleo PR, Guadagno PA, Roberts R, et al. Early diagnosis of acute myocardial infarction based on assay for subforms of creatine kinase-MB. Circulation 1990;82:759-64.
43. Wu AH, Wang XM, Gornet TG, et al. Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection of acute myocardial infarction. Clin Chem 1992;38:2396-400.
44. Zimmerman J, From R, Meyer D, et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation 1999;99:1671-7.
45. Roe CR, Limbird LE, Wagner GS, et al. Combined isoenzyme analysis in the diagnosis of myocardial injury: Application of electrophoretic methods for the detection and quantitation of the creatine phosphokinase MB isoenzyme. J Lab Clin Med 1972;80:577.
46. Mercer DW. Separation of tissue and serum creatine kinase isoenzymes by ion-exchange column chromatography. Clin Chem 1974;20:36-40.
47. Roberts R, Sobel BE, Parker CW. Radioimmunoassay for creatine kinase isoenzymes. Science 1976;194:855-7.
48. Bruns DE, Chitwood J, Koller K, et al. Creatine kinase- MB activity: clinical and laboratory studies of specific immunochemical technique with optimized enzymatic assay. Ann Clin Lab Sci 1983;13:59-66.
49. World Health Organization. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979;59:607-9.
50. Szasz G, Gruber W, Bernt E. Creatine kinase in serum: 1. Determination of optimum reaction conditions. Clin Chem 1976;22:650-6.
51. Young DS, Pestaner LC, Gibberman V. Effects of drugs on clinical laboratory tests. Clin Chem 1975;21:1D-432D.
52. Perry B, Doumas B, Jendrzejczak B. Effect of light and temperatare on the stability of creatine kunase in human sera and controls. Clin Chem 1979;25:625-8.
53. Dalal FR, Chilley J Jr, Winsten S. A study of the problems of inactivation of creatine kinase in serum. Clin Chem1972;18:330-4.
54. Szasz G, Gerhardt W, Gruber W. Creatine kinase in serum: 5. Effect of thiols on isoenzyme activity during storage at various temperatures. Clin Chem 1978;24:1557-63.
55. Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Circulation 1993;88:750-63.
56. Ohman EM, Casey C, Bengtson JR, et al. Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation. Br Heart J 1990;63:335-8.
57. French JK, White HD. Clinical implications of the new definition of myocardial infarction. Heart 2004;90:99-106.
58. Plebani M, Zaninotto M. Diagnostic strategies using myoglobin measurement in myocardial infarction. Clin Chim Acta 1998;272:69-77.
59. Gilkeson G, Stone MJ, Waterman M, et al. Detection of myoglobin by radioimmunoassay in human sera: its usefulness and limitations as an emergency room screening test for acute myocardial infarction. Am Heart J 1978;95:70-7.
60. Varki AP, Roby DS, Watts H, et al. Serum myoglobin in acute myocardial infarction: a clinical study and review of the literature. Am Heart J 1978;96:680-8.
61. Schultz A, Larsen CE, Kristensen SD, et al. Serum myoglobin measured by latex agglutination: rapid test for exclusion of acute myocardial infarction. Am Heart J 1986;112:609-10.
62. Gibler WB, Gibler CD, Weinshenker E, et al. Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med 1987;16:851-6.
63. Wu AHB, Laios I, Green S, et al. Immunoassays for serum and urine myoglobin: myoglobin clearance assessed as a risk factor for acute renal failure. Clin Chem 1994;40:796-802.
64. de Winter RJ, Koster RW, Sturk A, et al. Value of myoglobin, troponin T, and CK-MB mass in ruling out an acute myocardial infarction in the emergency room. Circulation 1995;92:3401-7.
65. Katus HA, Diederich KW, Scheffold T, et al. Noninvasive assessment of infarct reperfusion: the predictive power of the time to peak value of myoglobin, CKMB, and CK in serum. Eur Heart J 1988;9:619-24.
66. Ellis AK, Little T, Masud AR, et al. Early noninvasive detection of successful reperfusion in patients with acute myocardial infarction. Circulation 1988;78:1352-7.
67. Grenadier E, Keidar S, Kahana L, et al. The roles of serum myoglobin, total CPK, and CK-MB isoenzyme in the acute phase of myocardial infarction. Am Heart J 1983;105:408-16.
68. Chan DW, Taylor E, Frye T, et al. Immunoenzymetric assay for creatine kinase MB with subunitspecific monoclonal antibodies compared with an immunochemical method and electrophoresis. Clin Chem 1985;31:465-9.
69. Vaidya HC, Maynard Y, Dietzler DN, et al. Direct measurement of creatine kinase-MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme. Clin Chem 1986;32:657-63.
70. Murthy VV, Karmen A. Activity concentration and mass concentration (monoclonal antibody immunoenzymometric method) compared for creatine kinase MB isoenzyme in serum. Clin Chem 1986;32:1956-9.
71. Bakker AJ, Gorgels JP, van Vlies B, et al. The mass concentrations of serum troponin T and creatine kinase- MB are elevated before creatine kinase and creatine kinase-MB activities in acute myocardial infarction. Eur J Clin Chem Clin Biochem 1993;31:715-24.
72. Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000;21:1502-13.
73. Pierce GF, Jaffe AS. Increased creatine kinase MB in the absence of acute myocardial infarction. Clin Chem 1986;32:2044-51.
74. el Allaf M, Chapelle JP, el Allaf D, et al. Differentiating muscle damage from myocardial injury by means of the serum creatine kinase (CK) isoenzyme MB mass measurement/total CK activity ratio. Clin Chem 1986;32:291-5.
75. Brandt DR, Gates RC, Eng KK, et al. Quantifying the MB isoenzyme of creatine kinase with the Abbott IMx immunoassay analyzer. Clin Chem 1990;36:375-8.
76. Jørgensen PJ, Hørder M, Selmer J, et al. Analytical evaluation of a sensitive enzyme immunoassay for the determinations of creatine kinase isoenzyme MB. Clin Chem 1990;36:1502-5.
77. Delanghe JR, De Mol AM, De Buyzere ML, et al. Mass concentration and activity concentration of creatine kinase isoenzyme MB compared in serum after acute myocardial infarction. Clin Chem 1990;36:149-53.
78. Ebashi S. Calcium binding and relaxation in the actomyosin system. J Biochem 1960;48:150-1.
79. Ebashi S. Calcium binding activity of vesicular relaxing factor. J Chir (Paris) 1961;82:236-44.
80. Ebashi S, Lipmann F. Adenosine triphosphate-linked concentration of calcium ions in a particulate fraction of rabbit muscle. J Cell Biol 1962;14:389-400.
81. Ebashi S, Third component participating in the superprecipitation of 'natural actomyosin'. Nature 1963;200:1010.
82. Ebashi S, Kodama A. A new protein factor promoting aggregation of tropomyosin. J Biochem 1965;58:107-8.
83. Ebashi S, Ebashi F, Kodama A. Troponin as the Ca++- receptive protein in the contractile system. J Biochem 1967;62:137-8.
84. Ebashi S, Endo M. Calcium and muscle contraction. Prog Biophys Mol Biol 1968;18:123-83.
85. Ebashi S, Endo M, Ohtsuki I. Control of muscle contraction. Q Rev Biophys 1969;2:351-84.
86. Otsuki I, Masaki T, Nonomura Y, et al. Periodic distribution of troponin along the thin filament. J Biochem 1967;61:817-9.
87. Greaser ML, Gergely J. Reconstitution of troponin activity from three protein components. J Biol Chem 1971;246:4226-33.
88. Collins JH, Potter JD, Horn MJ, et al. The amino acid sequence of rabbit skeletal muscle troponin C: gene replication and homology with calcium-binding proteins from carp and hake muscle. FEBS Lett 1973;36:268-72.
89. Wilkinson JM, Grand RJ. Comparison of amino acid sequence of troponin I from different striated muscles. Nature 1978;271:31-5.
90. Leavis PC, Gowell E, Tao T. Fluorescence lifetime and acrylamide quenching studies of the interactions between troponin subunits. Biochemistry 1984;23:4156-61.
91. Herzberg O, James MN. Structure of the calcium regulatory muscle protein troponin-C at 2.8 A resolution. Nature 1985;313:653-9.
92. Hitchcock-De Gregori SE. Study of the structure of troponin-I by measuring the relative reactivities of lysines with acetic anhydride. J Biol Chem 1982;257:7372-80.
93. Vassylyev DG, Takeda S, Wakatsuki S, et al. Crystal structure of troponin C in complex with troponin I fragment at 2.3-A resolution. Proc Natl Acad Sci U S A 1998;95:4847-52.
94. Dhoot GK, Frearson N, Perry SV. Polymorphic forms of troponin T and troponin C and their localization in striated muscle cell types. Exp Cell Res 1979;122:339-50.
95. Mikawa T, Takeda S, Shimizn T, et al. Gene expression of myofibrillar proteins in single muscle fibers of adult chicken: micro two dimensional gel electrophoretic analysis. J Biochem 1981;89:1951-62.
96. Bucher EA, Maisonpierre PC, Konieczny SF, et al. Expression of the troponin complex genes: transcriptional coactivation during myoblast differentiation and independent control in heart and skeletal muscles. Mol Cell Biol 1988;8:4134-42.
97. Fatkin D, Graham RM. Molecular mechanism of inherited cardiomyopathies. Physiol Rev 2002;82:945-80.
98. Harada K, Potter JD. Familial hypertrophic cardiomyopathy mutations from different functional regions of troponin T result in different effects on the pHand Ca2+-sensitivity of cardiac muscle contraction. J Biol Chem 2004;279:14488-95.
99. Lippi G, Cervellin G. Genetic polymorphisms of human cardiac troponins as an unrecognized challenge for diagnosing myocardial injury. Int J Cardiol 2014;171:467-70.
100. Cummins B, Auckland ML, Cummins P. Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 1987;113:1333-44.
101. Larue C, Defacque-Lacquement H, Calzolari C, et al. New monoclonal antibodies as probes for human cardiac troponin I: Epitopic analysis with synthetic peptides. Mol Immunol 1992;29:271-8.
102. Bodor GS, Porter S, Landt Y, et al. Development of monoclonal antibodies for an assay of cardiac troponin I and preliminary results in suspected cases of myocardial infarction. Clin Chem 1992;38:2203-14.
103. Adams III JE, Bodor GS, Dávila-Román VG, et al. Cardiac troponin I: a marker with high specificity for cardiac injury. Circulation 1993;88:101-6.
104. Lippi G, Salvagno GL, Da Rin G, et al. Harmonization of contemporary-sensitive troponin I immunoassays: calibration may only be a part of the problem. Riv Ital Med Lab 2014;10:108-14.
105. Salvagno GL, Giavarina D, Meneghello M, et al. Multicenter Comparison of Four Contemporary Sensitive Troponin Immunoassays. J Med Biochem 2014;33:271-7.
106. Apple FS. Counterpoint: Standardization of cardiac troponin I assays will not occur in my lifetime. Clin Chem 2012;58:169-71.
107. Jarolim P. High sensitivity cardiac troponin assays in the clinical laboratories. Clin Chem Lab Med. 2015;53:635-52.
108. Katus HA, Remppis A, Looser S, et al. Enzyme-linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol 1989;21:1349-53.
109. Katus HA, Looser S, Hallermeyer K, et al. Development and in vitro characterization of a new immunoassay of cardiac troponin T. Clin Chem 1992;38:386-93.
110. Müller-Bardorff M, Hallermeyer K, Schroder A, et al. Improved Troponin T ELISA specific for cardiac Troponin T isoform: assay development and analytical and clinical validation. Clin Chem 1997;43:458-66.
111. Hoyle NR, Eckert B, Krais S. Electrochemiluminescence: leading-edge technology for automated immunoassay analyte detection. Clin Chem 1996;42:1576-8.
112. Hallermayer K, Klenner D, Vogel R. Use of recombinant human cardiac Troponin T for standardization of third generation Troponin T methods. Scand J Clin Lab Invest Suppl 1999;230:128-31.
113. Hermsen D, Apple F, Garcia-Beltran L, et al. Results from a multicenter evaluation of the 4th generation Elecsys Troponin T assay. Clin Lab 2007;53:1-9.
114. Giannitsis E, Kurz K, Hallermayer K, et al. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56:254-61.
115. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60:1581-98.
116. Apple FS, Collinson PO. Analytical characteristics of highsensitivity cardiac troponin assays. Clin Chem 2012;58:54-61.
117. Lippi G. The mystifying nomenclature of cardiac troponin immunoassays. Scand J Clin Lab Invest 2014;74:273-7.
118. Roziakova L, Bojtarova E, Mistrik M, et al. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation. J Exp Clin Cancer Res 2012;31:13.
119. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-67.
120. Weber M, Bazzino O, Navarro Estrada JL, et al. Improved diagnostic and prognostic performance of a new highsensitive troponin T assay in patients with acute coronary syndrome. Am Heart J 2011;162:81-8.
121. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-77.
122. Keller T, Zeller T, Ojeda F, et al. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-93.
123. Lippi G. Biomarkers of myocardial ischemia in the emergency room: cardiospecific troponin and beyond. Eur J Intern Med 2013;24:97-9.
124. Lippi G, Buonocore R, Schirosa F, et al. Cardiac troponin I is increased in patients admitted to the emergency department with severe allergic reactions. A case-control study. Int J Cardiol 2015;194:68-9.
125. Agewall S, Giannitsis E, Jernberg T, et al. Troponin elevation in coronary vs. non-coronary disease. Eur Heart J 2011;32:404-11.